Picture of Sienna Biopharmaceuticals logo

SNNAQ Sienna Biopharmaceuticals Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Annual cashflow statement for Sienna Biopharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2015
December 31st
2016
December 31st
2017
December 31st
2018
December 31st
Period Length:12 M12 M12 M12 M
Source:PROSPECTUSPROSPECTUS10-K10-K
Standards:
USG
USG
USG
USG
Status:FinalFinalFinalFinal
Net Income/Starting Line-11.3-21.2-50.5-73.5
Depreciation
Non-Cash Items1.20.9817.898.46
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.0882.431.453.17
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Cash from Operating Activities-9.98-17.7-41.1-61.7
Capital Expenditures-0.088-0.238-0.274-0.039
Purchase of Fixed Assets
Other Investing Cash Flow Items0-6.820.0080
Acquisition of Business
Sale of Fixed Assets
Cash from Investing Activities-0.088-7.06-0.266-0.039
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities14.628.810736
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash4.554.1365.4-25.9